FineHeart strengthens its Board of Directors with the appointment of Pierre Chauvineau

martedì 2 giugno 2026 New tab

949 words~4 min read

An international medtech executive to support the company’s scale-up

FineHeart, a French clinical-stage medtech company developing FlowMaker®, a breakthrough therapy for the treatment of advanced heart failure, announces the appointment of Pierre Chauvineau as a member of its Board of Directors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602949700/en/

Pierre Chauvineau

FineHeart strengthens its Board of Directors with the appointment of Pierre Chauvineau — Warptech Lab News

FineHeart strengthens its Board of Directors with the appointment of Pierre Chauvineau

FineHeart strengthens its Board of Directors with the appointment of Pierre Chauvineau

Other newsrooms on this story

Related reading

CardioMech Shareholders Appoint Ramin Mousavi as Chairman of the Board

Sensorion Appoints Fred Chereau as Chief Executive Officer

Theraclion Announces the Evolution of Its Board of Directors

Virchow Medical Strengthens Scientific Advisory Board with New Appointments

F5 Adds Gavin Munroe to its Board of Directors

EHE Health Appoints Chief Medical Officer to Advance Clinical Strategy

Other newsrooms on this story

Related reading

CardioMech Shareholders Appoint Ramin Mousavi as Chairman of the Board

Sensorion Appoints Fred Chereau as Chief Executive Officer

Theraclion Announces the Evolution of Its Board of Directors

Virchow Medical Strengthens Scientific Advisory Board with New Appointments

F5 Adds Gavin Munroe to its Board of Directors

EHE Health Appoints Chief Medical Officer to Advance Clinical Strategy